Anti-idiotype Antibodies

Q: What is an anti-idiotype antibody?

An anti-idiotype (anti-Id) antibody specifically recognizes the unique antigen-binding region (idiotype) of a therapeutic antibody. It is used as a surrogate positive control in ADA assays and as a calibrator or detection reagent in PK assays.

Q: What assay formats do your anti-Id antibodies support?

Our anti-idiotype antibodies are validated for bridging ELISA (ADA screening/confirmation), sandwich ELISA (PK measurement), electrochemiluminescence (MSD), and cell-based neutralizing antibody assays.

Q: Can you develop custom anti-idiotype antibodies for my drug?

Yes. Our parent company AtaGenix provides end-to-end custom anti-idiotype antibody development — from immunization strategy through hybridoma screening, epitope characterization, and scale-up production with full QC documentation.

Q: How are anti-idiotype antibodies used in PK vs ADA assays?

In PK assays, anti-Id antibodies serve as capture or detection reagents to quantify drug concentration in serum. In ADA assays, they act as surrogate positive controls that mimic patient anti-drug antibody responses for assay validation and cut-point determination.

Accelerate your bioanalytical method development with anti-idiotype (anti-Id) antibodies — validated surrogate positive controls for ADA immunogenicity assays and calibrator/detection reagents for PK drug-level quantification. Covering major biologic drug targets including adalimumab, bevacizumab, trastuzumab, nivolumab, pembrolizumab, and more. Custom anti-Id development available through our parent company AtaGenix. RUO

Why Researchers Choose abinScience

Purpose-Built for Bioanalysis Anti-idiotype antibodies specifically designed and validated for PK and ADA ELISA workflows — not repurposed research antibodies.

Broad Drug Target Coverage Catalog anti-Id antibodies against adalimumab, bevacizumab, trastuzumab, rituximab, infliximab, nivolumab, pembrolizumab, atezolizumab, durvalumab, and expanding.

Assay-Format Validated Validated for bridging ELISA, sandwich ELISA, MSD/ECL, and cell-based neutralizing antibody (NAb) assay formats with application data provided.

Custom Anti-Id Development End-to-end service from AtaGenix — immunization strategy, hybridoma screening, epitope binning, and GLP-compatible scale-up with full characterization.

Complete PK/ADA Reagent Sets Matched pairs of capture anti-Id, detection anti-Id, and drug calibrator proteins — streamline your assay development with one supplier.

How to Select the Right Product

Identify your drug target: Find the therapeutic antibody you need to monitor (e.g., adalimumab, trastuzumab). Search by drug name or target antigen.
Define assay purpose: PK assay — select capture and/or detection anti-Id pairs for drug concentration measurement. ADA assay — select surrogate positive control anti-Id for cut-point validation.
Choose binding epitope: Paratope-binding anti-Id mimics target antigen; non-paratope-binding anti-Id for detection without drug interference. Contact us for epitope mapping data.
Verify format compatibility: Confirm the anti-Id format (unconjugated, biotinylated, HRP-labeled) matches your detection platform (ELISA, MSD, Gyros).

Documents & QC Data

Download product datasheets, binding affinity data (SPR/BLI), CoA, and assay validation protocols on each product page. All data is lot-specific.

FAQs

What is an anti-idiotype antibody?

An anti-idiotype (anti-Id) antibody specifically recognizes the unique antigen-binding region (idiotype) of a therapeutic antibody. It is used as a surrogate positive control in ADA assays and as a calibrator or detection reagent in PK assays.

What assay formats do your anti-Id antibodies support?

Our anti-idiotype antibodies are validated for bridging ELISA (ADA screening/confirmation), sandwich ELISA (PK measurement), electrochemiluminescence (MSD), and cell-based neutralizing antibody (NAb) assay formats.

Can you develop custom anti-idiotype antibodies for my drug?

Yes. Our parent company AtaGenix provides end-to-end custom anti-idiotype antibody development — from immunization strategy through hybridoma screening, epitope characterization, and scale-up production with full QC documentation.

How are anti-idiotype antibodies used in PK vs ADA assays?

In PK assays, anti-Id antibodies serve as capture or detection reagents to quantify drug concentration in serum. In ADA assays, they act as surrogate positive controls that mimic patient anti-drug antibody responses for assay validation and cut-point determination.

What drug targets do you cover?

We offer catalog anti-idiotype antibodies against major biologic drugs including adalimumab, bevacizumab, trastuzumab, rituximab, infliximab, nivolumab, pembrolizumab, atezolizumab, and many more. Custom development is available for any therapeutic antibody.